-
Wegovy pill could increase access to obesity treatment
BY MELISSA PATRICK KENTUCKY HEALTH NEWS The U.S. Food and Drug Administration has approved the first pill version of a GLP-1 drug for weight loss, a move that could significantly widen access to the treatment for obesity. The once-daily Wegovy pill, made by Danish company Novo Nordisk, is expected to launch in early January. Novo
